The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (16 analysts) rates it buy, with a mean price target of $103.
Textron TXT
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Textron Inc.
read at $91.48
Textron holds its Markup at $91.48.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 17 days |
| Price | $91.48 |
| Valuation | 17.46 trailing · 12.56 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.91 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades at roughly a 26% discount to our $115.00 fair value, narrow competitive moat, 11.80% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | 11.80% |
| Profit margin | 6.15% |
| Debt to equity | 52.67 |
| Analyst consensus | Buy · 16 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Business activity: Aerospace & Defense Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Textron trips on defence work before numbers matter
Textron keeps Bell helicopters and Cessna jets moving through government and corporate hands every year. We pass because the business activity screen rules out any stake on ethical grounds, full stop.
Revenue climbs 12 percent yet the 6 percent profit margin and 12 percent ROE sit behind a narrow moat. The 12.6 times forward multiple and 26 percent gap to fair value cannot override that hard block.
Defence cycles add their own swings while 16 analysts still push a 100 dollar target. Analysis, not advice.
| Forward P/E | 12.6x fairly priced for its growth rate |
| Trailing P/E | 17.5x reasonably valued |
| Revenue growth | 11.8% steady growth |
| Profit margin | 6.2% thin but positive margins |
| Return on equity | 12.3% a solid return on shareholder capital |
| Debt to equity | 0.53 moderate, manageable leverage |
| Current ratio | 1.85 healthy short-term liquidity |
| Beta | 0.91 steadier than the market |
| Market cap | $15.9B |
| Employees | 34,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in TXT's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
TXT trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-06 | CLARK RONALD KERRY | Director | 2,517 | $234,308 | |
| 2026-05-01 | KENNEDY THOMAS A | Director | 10,300 | $988,594 | |
| 2026-04-29 | KENNEDY THOMAS A | Director | 2,061 | · | |
| 2026-04-29 | CLARK RONALD KERRY | Director | 2,061 | · | |
| 2026-04-29 | NOWELL LIONEL L III | Director | 2,061 | · | |
| 2026-04-29 | JAMES DEBORAH LEE | Director | 2,061 | · | |
| 2026-04-29 | AMBROSE RICHARD F. | Director | 2,061 | · | |
| 2026-04-29 | ZUBER MARIA T. | Director | 2,061 | · | |
| 2026-04-29 | MIONIS ROBERT ANDREW | Director | 2,061 | · | |
| 2026-04-29 | GARRETT MICHAEL X | Director | 2,061 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $91.66 | -0.3% | · | $997 | -0.3% |
| 2 months | $91.39 | 0.0% | · | $1,000 | 0.0% |
| 3 months | $91.52 | -0.2% | $0.02 | $999 | -0.1% |
| 6 months | $86.81 | +5.2% | $0.04 | $1,053 | +5.3% |
| 1 year | $77.78 | +17.5% | $0.08 | $1,176 | +17.6% |
| 2 years | $86.17 | +6.0% | $0.16 | $1,062 | +6.2% |
| 3 years | $65.12 | +40.3% | $0.22 | $1,406 | +40.6% |
| 5 years | $68.04 | +34.3% | $0.38 | $1,348 | +34.8% |
Historical returns from market close data. Past performance does not guarantee future results.